Impact of Fostemsavir in Individuals with Multidrug-Resistant HIV-1, Stratified by Baseline Viral Load. (PubMed, Infect Dis Ther) - Sep 13, 2026 - P3 | "Findings support considering fostemsavir for regimen optimization in individuals with limited treatment options and undetectable/low VL, especially if safety/tolerability may be a concern."
Journal • Human Immunodeficiency Virus • Infectious Disease • CD4 • CD8
|
|
Alftan Dyson; Bo Li; Bruce Gilliam; Bryn Jones; Fangfang Du; Manyu Prakash; Marcia Wang; Michelle Moorhouse
|